A NEW PROSPECT FOR WEIGHT CONTROL ?

Scientists are increasingly examining retatrutide, a promising medication created by Eli Lilly, as a potential breakthrough in body reduction . Unlike many previous approaches, retatrutide is a dual -action receptor targeting both GLP-1 and GIP, chemicals that impact satiety and glucose balance.